Skip to content

The impact of Florabile syrup on intensity of Psoriasis rashes.

The impact of Florabile syrup on intensity (inflammation, plaque, and scaling) of Psoriasis rashes in patients aged 20 to 50 years.

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200408047000N1
Enrollment
25
Registered
2020-05-04
Start date
2019-03-16
Completion date
Unknown
Last updated
2020-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psoriasis. Psoriasis

Interventions

Experimental group: Consumer of Florabil syrup consisting:Tamarindus indica, Prune's domestica, Prune's spinosa L, Ziziphus juijub mill, Cordia myxa, Prunus armeniaca, Manna
and the benefits of this syrup includes increasing bile flow and facilitate it to exit the body, cleansing and strengthening the liver, controlling liver heat, removing tongue and skin dryness. No spe
and they diluted Florabile Syrup from Farateb company of Yazd containing three spoons (each spoon with an approximate volume of 15cc) with a glass of water and consumed one hour before lunch daily..

Sponsors

Esfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 50 Years

Inclusion criteria

Inclusion criteria: The patient must be between 20 to 50 years old. Patients should have mild to moderate Psoriasis and their body should be involved less than 20%. If patient has taken any other drugs to treat Psoriasis, he or she should not consume new dug for three months.

Exclusion criteria

Exclusion criteria: Patients with generalized, unstable, or pustular Psoriasis who have only skull, nails, flexor surfaces or palms and soles involvement. Patients who are pregnant or breastfeeding. Patients who are allergic to plums, jujube, and Tamarindus indica-derived products.

Design outcomes

Primary

MeasureTime frame
Suitable (PASI; Psoriasis Area Severity Index) for any patient. Timepoint: At the beginning of the study (Before intervention) and after finishing the study. Method of measurement: The software of calculating Psoriasis Severity Area Index. Version 1.7.2.;Percent of patients body surface involved (BSA; Body Surface Area). Timepoint: At the beginning of the study (Before intervention) and after finishing the study. Method of measurement: Calculating formula of the Percent of patients body surface involved.;Erythema (redness) of Psoriasis rashes. Timepoint: At the beginning of the study (Before intervention) and after finishing the study. Method of measurement: Observation.;Induration (plaque) of Psoriasis rashes. Timepoint: At the beginning of the study (Before intervention) and after finishing the study. Method of measurement: Observation.;Desquamation (scaling) of Psoriasis rashes. Timepoint: At the beginning of the study (Before intervention) and after finishing the study. Method of measurement: Observation.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAmeneh Parastegari

Esfahan University of Medical Sciences

mahdavi88311388@gmail.com+98 31 3324 3522

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026